PMID- 28390174 OWN - NLM STAT- MEDLINE DCOM- 20180102 LR - 20210514 IS - 1097-4644 (Electronic) IS - 0730-2312 (Linking) VI - 118 IP - 11 DP - 2017 Nov TI - Suppression of Basic Fibroblast Growth Factor Expression by Antisense Oligonucleotides Inhibits Neural Stem Cell Proliferation and Differentiation in Rat models With Focal Cerebral Infarction. PG - 3875-3882 LID - 10.1002/jcb.26038 [doi] AB - This study is designed to investigate the role of basic fibroblast growth factor (bFGF) antisense oligonucleotide (ASODN) on the proliferation and differentiation of neural stem cells (NSCs) in rat models with focal cerebral infarction (CI). Seventy-five Sprague-Dawlay (SD) rats were randomly divided into the control, sham, middle cerebral artery occlusion (MCAO), MCAO + nonsense oligonucleotide (NODN), and MCAO + ASODN groups. Proliferation and differentiation of NSCs were detected by bromodeoxyuridine (BrdU) and immunofluorescence staining, respectively. ELISA was performed to detect the expressions of endogenous factors that include insulin-like growth factor 1 (IGF-1), glial cell line derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), transforming growth factor-alpha1 (TGF-alpha1), bFGF, and nerve growth factor (NGF). Results show significant neurological deficits and focal CI in the MCAO and MCAO + NODN groups. An obvious increase of NSC proliferation, reactive proliferation of astrocytes in CI areas, differentiation of newly proliferated NSCs into mature neuronal cells, and expressions of endogenous growth factors exhibited in the MCAO, MCAO + NODN and MCAO + ASODN groups. Compared to the MCAO and MACO + NODN groups, the MCAO + ASODN group showed a significant decrease NSC proliferation and differentiation in CI areas as well as decrease expressions of endogenous growth factors. These findings may offer insight to help us understand more as to how bFGF ASODN can effectively suppress the proliferation and differentiation of NSCs. These findings are expected to help contribute to research for new targets in the treatment of focal CI. J. Cell. Biochem. 118: 3875-3882, 2017. (c) 2017 Wiley Periodicals, Inc. CI - (c) 2017 Wiley Periodicals, Inc. FAU - Li, Chao AU - Li C AD - Department of Neurology, The First Hospital of Jilin University, Changchun, 130021, P.R. China. FAU - Che, Li-He AU - Che LH AD - Department of Infectious Diseases, The First Hospital of Jilin University, Changchun, 130021,, P.R. China. FAU - Shi, Lei AU - Shi L AD - Department of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021,, P.R. China. FAU - Yu, Jin-Lu AU - Yu JL AD - Department of Neurosurgery, The First Hospital of Jilin University, Changchun, 130021,, P.R. China. LA - eng PT - Journal Article PT - Retracted Publication DEP - 20170523 PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Oligodeoxyribonucleotides, Antisense) RN - 103107-01-3 (Fibroblast Growth Factor 2) SB - IM RIN - J Cell Biochem. 2021 Jul;122(7):770. PMID: 33988269 MH - Animals MH - Cell Differentiation/*drug effects MH - Cell Proliferation/*drug effects MH - Cerebral Infarction/*metabolism/pathology MH - Fibroblast Growth Factor 2/*antagonists & inhibitors/biosynthesis MH - Gene Expression Regulation/*drug effects MH - Neural Stem Cells/*metabolism/pathology MH - Oligodeoxyribonucleotides, Antisense/*pharmacology MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - ANTISENSE OLIGONUCLEOTIDE OT - DIFFERENTIATION OT - FOCAL CEREBRAL INFARCTION OT - NEURAL STEM CELLS OT - PROLIFERATION OT - bFGF EDAT- 2017/04/09 06:00 MHDA- 2018/01/03 06:00 CRDT- 2017/04/09 06:00 PHST- 2017/02/22 00:00 [received] PHST- 2017/04/07 00:00 [accepted] PHST- 2017/04/09 06:00 [pubmed] PHST- 2018/01/03 06:00 [medline] PHST- 2017/04/09 06:00 [entrez] AID - 10.1002/jcb.26038 [doi] PST - ppublish SO - J Cell Biochem. 2017 Nov;118(11):3875-3882. doi: 10.1002/jcb.26038. Epub 2017 May 23.